Cargando…
Screening for hepatitis C in psychiatric population
INTRODUCTION: A meta-analysis from 2016 estimates prevalence of hepatitis C to be superior in people with severe mental illness than general population. In France, positivity for hepatitis C is estimated at 0,75% of general population and 0.3% with a detectable viral load. No recent study was conduc...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470817/ http://dx.doi.org/10.1192/j.eurpsy.2021.267 |
_version_ | 1784788922313736192 |
---|---|
author | Icole, F. Bronowicki, J.-P. Jeannoel, C. Besancon, P. Boulanger, F. |
author_facet | Icole, F. Bronowicki, J.-P. Jeannoel, C. Besancon, P. Boulanger, F. |
author_sort | Icole, F. |
collection | PubMed |
description | INTRODUCTION: A meta-analysis from 2016 estimates prevalence of hepatitis C to be superior in people with severe mental illness than general population. In France, positivity for hepatitis C is estimated at 0,75% of general population and 0.3% with a detectable viral load. No recent study was conducted to determine seroprevalence of hepatitis C in population admitted in psychiatric institution. OBJECTIVES: The aims of this study are to determine seroprevalence of hepatitis C in population admitted in psychiatric institution and describe the profile of infected patients. METHODS: From january 2020 to october 2020, screening test for hepatitis C, hepatitis B and HIV was proposed to every patient admitted at the reception unit of Ravenel Hospital. In case of positivity, viral load was realised. RESULTS: Between January 7(th) and Octobre 1(st) , 407 patients greed to the screening test. Among them, 17 (4,2%) were tested positive to hepatits C and viral load was detectable in 9/17 positives, which lead to a 2,2% seroprevalence of hepatitis C infection in the studied population. The patients with positive screening had a mean age of 40 years old. 82% of them were males. 16 admit using intoxicating substances and 10 were still current users at the time of the study. They were hospitalized for addictology purpose (5/17), psychosis (6/17), mood disorder (5/17), personality disorder (2/17), adjustement disorder (2/7). 10/17 had an alcohol use disorder. CONCLUSIONS: This study confirms seroprevalence of hepatitis C infection in psychiatric population is seven times that of general population. This justifies a systematic screening of this population. DISCLOSURE: No significant relationships. |
format | Online Article Text |
id | pubmed-9470817 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-94708172022-09-29 Screening for hepatitis C in psychiatric population Icole, F. Bronowicki, J.-P. Jeannoel, C. Besancon, P. Boulanger, F. Eur Psychiatry Abstract INTRODUCTION: A meta-analysis from 2016 estimates prevalence of hepatitis C to be superior in people with severe mental illness than general population. In France, positivity for hepatitis C is estimated at 0,75% of general population and 0.3% with a detectable viral load. No recent study was conducted to determine seroprevalence of hepatitis C in population admitted in psychiatric institution. OBJECTIVES: The aims of this study are to determine seroprevalence of hepatitis C in population admitted in psychiatric institution and describe the profile of infected patients. METHODS: From january 2020 to october 2020, screening test for hepatitis C, hepatitis B and HIV was proposed to every patient admitted at the reception unit of Ravenel Hospital. In case of positivity, viral load was realised. RESULTS: Between January 7(th) and Octobre 1(st) , 407 patients greed to the screening test. Among them, 17 (4,2%) were tested positive to hepatits C and viral load was detectable in 9/17 positives, which lead to a 2,2% seroprevalence of hepatitis C infection in the studied population. The patients with positive screening had a mean age of 40 years old. 82% of them were males. 16 admit using intoxicating substances and 10 were still current users at the time of the study. They were hospitalized for addictology purpose (5/17), psychosis (6/17), mood disorder (5/17), personality disorder (2/17), adjustement disorder (2/7). 10/17 had an alcohol use disorder. CONCLUSIONS: This study confirms seroprevalence of hepatitis C infection in psychiatric population is seven times that of general population. This justifies a systematic screening of this population. DISCLOSURE: No significant relationships. Cambridge University Press 2021-08-13 /pmc/articles/PMC9470817/ http://dx.doi.org/10.1192/j.eurpsy.2021.267 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Abstract Icole, F. Bronowicki, J.-P. Jeannoel, C. Besancon, P. Boulanger, F. Screening for hepatitis C in psychiatric population |
title | Screening for hepatitis C in psychiatric population |
title_full | Screening for hepatitis C in psychiatric population |
title_fullStr | Screening for hepatitis C in psychiatric population |
title_full_unstemmed | Screening for hepatitis C in psychiatric population |
title_short | Screening for hepatitis C in psychiatric population |
title_sort | screening for hepatitis c in psychiatric population |
topic | Abstract |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470817/ http://dx.doi.org/10.1192/j.eurpsy.2021.267 |
work_keys_str_mv | AT icolef screeningforhepatitiscinpsychiatricpopulation AT bronowickijp screeningforhepatitiscinpsychiatricpopulation AT jeannoelc screeningforhepatitiscinpsychiatricpopulation AT besanconp screeningforhepatitiscinpsychiatricpopulation AT boulangerf screeningforhepatitiscinpsychiatricpopulation |